OpenAI Founder Sam Altman Invests $180 Million in Life-Extension Startup
OpenAI’s founder Sam Altman has a finger in more than one tech pie, so to speak. The controversial former president of startup accelerator, Y Combinator, and current ChatGPT kingpin isn’t only interested in getting his company’s artificial intelligence-powered chatbot into classrooms. He’s also interested in living forever—or at least longer than current human lifespan researchers suggest is possible. Altman has banked big bucks on a biotech startup, Retro Biosciences, as first reported Wednesday by MIT Technology Review.…